ActHib was administered with sterile water instead of saline with no reported adverse event; Initial information received on 21-Jan-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age/gender patient to whom HIB (PRP/T) VACCINE [ACT-HIB] was administered with sterile water instead of saline with no reported adverse event. The patient’s past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE, Powder and solvent for solution for injection (dose, strength, lot, expiry and route: unknown) with sterile water instead of saline with no reported adverse event (product preparation error) (latency same day) in unknown administration site for immunization. Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder’s compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.